“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Related posts:
John Paulson: Puerto Rico Is Now 'Singapore of the Caribbean'
Europeans slammed by austerity measures now enraged by political corruption
US blocks G20 crackdown on tax avoidance by net firms like Google and Amazon
California Democrats' blueprint for the election: 'Go left'
Eyewitnesses describe the terror of DWI checkpoint shooting
Police Steal $160,000 From Man During Traffic Stop
Julian Assange on Real Time With Bill Maher: NDAA Kill List
Lawsuit: State police destroyed woman's home without reason during raid
New bitcoin billing platform rolled out to marijuana dispensaries
South Africa Families Queue for Food as Strike Continues
50 Cent forgot he had a stash of Bitcoin now worth $8m
Brunei Darussalam looks to a new stock bourse to diversify economy
'Let's tax the sun': new Spanish law shocks world press
US Senate insists Washington prevent nuclear Iran
Security Meltdown at Republican Convention in Tampa